Programmable Immunity: DNA Nanostructures in Cancer Immunotherapy.
Despite significant progress in cancer immunotherapy, challenges such as limited immune activation, tumor immune evasion, low response rates in solid tumors and off-target effects continue to hinder therapeutic efficacy. These challenges necessitate strategies to remodel the immune-suppressive tumor microenvironment (T...